StonvexLoading…
StonvexStonvexStonvexCore line items from XLO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $12.65M | $43.77M | $30.08M | $11.01M |
Operating Income | $-14.11M | $-41.98M | $-30.15M | $-28.22M |
Net Income | $-9.53M | $-35.04M | $-45.40M | $-29.11M |
EPS (Diluted) | $-0.58 | $-4.19 | $-0.43 | $-0.34 |
Total Assets | $163.49M | $154.69M | $133.69M | $133.81M |
Total Liabilities | $90.94M | $119.41M | $141.79M | $126.74M |
Cash & Equivalents | $150.33M | $137.53M | $103.76M | $121.55M |
Free Cash Flow OCF − CapEx | $-22.90M | $-5.51M | $-3.42M | $14.08M |
Shares Outstanding | 5.78M | 4.53M | 51.83M | 51.83M |